Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence

La inmunoterapia antes y después de la cirugía de cáncer de pulmón reduce el riesgo de muerte y la recurrencia de la enfermedad

Las personas con cánceres de pulmón de células no pequeñas operables tienen un riesgo reducido de muerte y recurrencia de la enfermedad si reciben tratamientos de inmunoterapia antes y después de la cirugía en lugar de solo antes de la cirugía, según un nuevo análisis de Centro Oncológico Johns Hopkins Kimmel investigadoras.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment